# Four Quadrants Transverse Abdominus Plane (4Q-TAP) Block With Plain and Liposomal Bupivacaine vs. Thoracic Epidermal Analgesia (TEA) in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) on an Enhanced Recovery Pathway

> **NCT03359811** · PHASE3 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 75 (actual)

## Conditions studied

- Peritoneal Cancer

## Interventions

- **DRUG:** Local Anesthetic Solution
- **DRUG:** Bupivacaine HCl
- **DRUG:** Liposomal Bupivacaine

## Key facts

- **NCT ID:** NCT03359811
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-27
- **Primary completion:** 2020-11-24
- **Final completion:** 2020-11-24
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2022-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03359811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03359811, "Four Quadrants Transverse Abdominus Plane (4Q-TAP) Block With Plain and Liposomal Bupivacaine vs. Thoracic Epidermal Analgesia (TEA) in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) on an Enhanced Recovery Pathway". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03359811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*